Targeting angiogenesis in advanced gastric cancer: Is this end of the road?
Abstract
Despite recent advances in the management of several solid
tumour types, gastric cancer remains a challenging disease to
treat. In 2008, gastric cancer accounted for almost one million
new cases and over 738,000 deaths, making it the fourth most
common malignancy and second most common cause of cancerrelated
death in the world (1).
tumour types, gastric cancer remains a challenging disease to
treat. In 2008, gastric cancer accounted for almost one million
new cases and over 738,000 deaths, making it the fourth most
common malignancy and second most common cause of cancerrelated
death in the world (1).